Cenobamate

4 trials 1 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

1 Sponsors

5 Countries

Phase III

Phase I (Other)

Phase III: 3 Phase I (Other): 1

Oversight events:

2 unexpected events across 2 trials

View oversight register →

Indications tested

Generalised tonic-clonic seizure 2 Partial seizures 2

Sponsors using this IMP

Sk Life Science Inc. 4

All trials

4 total

A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generali… Recruiting

2023-506688-32-00 Phase III 5 countries Sk Life Science Inc.
"Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Children with Partial-onset (Focal) Seizures " Ended

2023-506841-52-00 Phase III 4 countries Sk Life Science Inc.
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Ended

2024-514045-11-00 Phase I (Other) 2 countries Sk Life Science Inc.
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Su… Ended

2023-506687-13-00 Phase III 5 countries Sk Life Science Inc.

Showing 1–4 of 4 trials

← All drugs A–Z